Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marwa O. El-Derany"'
Autor:
Hany N. Azzam, Marwa O. El-Derany, Sara A. Wahdan, Reham M. Faheim, Gouda K. Helal, Ebtehal El-Demerdash
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract We sought in our cross-sectional study to investigate the role of metabolic/hypoxial axis in the development of tamoxifen (TMX) resistance in BC patients. Quantification of plasma LncRNA Taurine upregulated-1 (TUG-1), miRNA 186-5p (miR-186),
Externí odkaz:
https://doaj.org/article/50bf80bedb1f42b3bbb85e9fc2b1511e
Publikováno v:
Stem Cell Reviews and Reports. 17:1429-1445
Radiotherapy is an indispensable cancer treatment approach. However, it is associated with hazardous consequences on multiple organs characterized by insidious worsening severity over time. This study aimed to examine the potential therapeutic effect
Autor:
Marwa O. El-Derany
Publikováno v:
Al-Azhar Journal of Pharmaceutical Sciences. 60:111-121
Chronic hepatitis C (CHC) treatment modalities dramatically evolve, however some patients still suffer treatment failure with sever aggressive side effects. Accordingly personalizing antiviral treatment becomes an urgent cornerstone in treatment path
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-23 (2021)
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-23 (2021)
Background Doxorubicin (DOX), a widely used chemotherapeutic agent, can cause neurodegeneration in the brain, which leads to a condition known as chemobrain. In fact, chemobrain is a deteriorating condition which adversely affects the lives of cancer
Autor:
Sayed A. Sayed, Hala O. El-Mesallamy, Marwa O. El-Derany, Sara A. Wahdan, Al-Aliaa M. Sallam, Rana K. El-Asfar, Ebtehal El-Demerdash
Publikováno v:
European journal of pharmacology. 908
Background and aim Tamoxifen (TAM) therapy has been associated with fatty liver diseases. Recently, multiple reports have also shown that TAM is related to cognitive impairment in patients with breast cancer. Luteolin, a natural flavonoid, has been t
Autor:
Fatma H. Shaker, Hala O. El-Mesallamy, Marwa O. El-Derany, Sara A. Wahdan, Ebtehal El-Demerdash
Publikováno v:
Life sciences. 269
Aims Cognitive decline is one of the most challenging issues for cancer survivors undergoing doxorubicin (DOX) based chemotherapy. Oxidative stress and inflammation primarily through tumor necrosis factor-alpha (TNF-α) are considered the key contrib
Autor:
Marwa O. El-Derany
Publikováno v:
Biology
Biology, Vol 9, Iss 75, p 75 (2020)
Volume 9
Issue 4
Biology, Vol 9, Iss 75, p 75 (2020)
Volume 9
Issue 4
Background: non-alcoholic steatohepatitis (NASH) recently headlined hepatocellular carcinoma (HCC) worldwide. This study aims to unveil the role of some unaddressed critical players that might aid in understanding, predicting, and targeting NASH and
Publikováno v:
Neurochemistry international. 138
Chemobrain is a well-established clinical syndrome that impairs patient's daily function, in particular attentiveness, coordination and multi-tasking. Thus, it interferes with patient's quality of life. The putative pharmacological intervention again
Autor:
Mahmoud E. S. Soliman, Marwa O. El-Derany, Mattia Tiboni, Enas Elmowafy, Luca Casettari, Francesca Biondo
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 12, Iss 2, p 143 (2020)
Volume 12
Issue 2
Pharmaceutics, Vol 12, Iss 2, p 143 (2020)
Volume 12
Issue 2
Flavonoids possess different interesting biological properties, including antibacterial, antiviral, anti-inflammatory and antioxidant activities. However, unfortunately, these molecules present different bottlenecks, such as low aqueous solubility, p
Autor:
Mona M. El-Naa, Eman M. Mantawy, Marwa O. El-Derany, Haidy E. Michel, Rania A. Salah El-Din, Heba H. Awad, Ebtehal El-Demerdash, Amany I. El-Brairy
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 140, Iss, Pp 111679-(2021)
The use of doxorubicin (DOX) to treat various tumors is limited by its cardiotoxicity. This study aimed to investigate and compare the cardioprotective effects of nicotinamide (NAM) and alfacalcidol (1α(OH)D3), against DOX-induced cardiotoxicity. Sp